Amenamevir

ANTIINFECTIVES FOR SYSTEMIC USE

Key facts

Amenamevir is a drug catalogued in DrugCentral. It was first approved by the PMDA in 2017. Recorded indications include Herpes zoster and Recurrent herpes simplex.

• Indications: Herpes zoster and Recurrent herpes simplex.
• ATC code: J05AX26 (Other antivirals).
• Molecular formula: C24H26N4O5S; molecular weight 482.56 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (2)

• Herpes zoster
• Recurrent herpes simplex

Regulatory approvals (1)

Date	Agency	Marketed as	Applicant	Orphan
2017-07-03	PMDA	—	Maruho

ATC classification

ATC code	Therapeutic hierarchy
J05AX26	ANTIINFECTIVES FOR SYSTEMIC USE › ANTIVIRALS FOR SYSTEMIC USE › DIRECT ACTING ANTIVIRALS › Other antivirals

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Amenamevir is on its molecule page.

• Molecular formula: C₂₄H₂₆N₄O₅S
• Molecular weight: 482.56 g/mol
• CAS number: —
• InChIKey: MNHNIVNAFBSLLX-UHFFFAOYSA-N
• PubChem CID: 11397521

CC1=CC=CC(C)=C1N(CC(=O)NC1=CC=C(C=C1)C1=NOC=N1)C(=O)C1CCS(=O)(=O)CC1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Amenamevir used for?

DrugCentral lists the following indications for Amenamevir: Herpes zoster and Recurrent herpes simplex.

When was Amenamevir first approved?

Amenamevir was first approved by the PMDA in 2017.

What is the chemical formula of Amenamevir?

Amenamevir has the molecular formula C24H26N4O5S and a molecular weight of 482.56 g/mol.

Sources

• DrugCentral drug card 5266 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
• ChEMBL CHEMBL4297592 — compound record and bioactivity
• PubChem CID 11397521 — chemical identifiers
• DrugBank DB11701 — drug record
• FDA UNII 94X46KW4AE — substance identity

How this page is built: methodology · editorial policy & corrections.